The Right Partner
In the race to bring new compounds to clinical trials, experience and dedication are everything. Many of our key personnel have wide experience in drug development from companies such as AstraZeneca, Pharmacia and Ferring. In fact, we have experience in taking compounds all the way from pre-clinical phase to product launch. Having focused on late pre-clinical and early clinical development for several decades, we know exactly what it takes to guide your way.
Our service portfolio, personal attention and focus on communication make us particularly suited to helping smaller biotechnology companies as well as those that need help navigating through often obscure regulatory requirements. While their needs may differ from those of our smaller partners, we have also successfully assisted large pharmaceutical companies including five of the worlds’ top ten. For all of our customers, we aim to accelerate drug development, cut costs and reduce the risks of pharmaceutical development.
With facilities in Södertälje, Sweden and Riga, Latvia, the majority of our staff are multi-lingual, Ph.D.-educated and have extensive international and industry experience. Each of our specialists is dedicated to delivering your project on time, and on budget. We continually strive to improve our service offering and accelerate your project in order to confirm that we are the right partner in the development of your drug.
- Founded in 1998 by former staff members of AstraZeneca
- Specializing in GMP and non-GMP manufacturing of small molecules
- Synthetic scale from mg to 100 kg
- Expertise in process development, medicinal chemistry, analytical services and crystallization
There may not be a single recipe for success, but at Syntagon you’re sure to find all the right ingredients